FDA Approves Movement Disorder Drug from CNS Therapeutics: Gablofen (Baclofen Injection) for the Treatment of Severe Spasticity
Links shared publicly online about this topic.
- 705total visits
FDA Approves Movement Disorder Drug from CNS Therapeutics: Gablofen (Baclofen Injection) for the Treatment of Severe Spasticity
View full resource at drugs.com
Tags: Nervous System, Movement Disorder, Disease and Condition, Drug, FDA
Most Recently Shared on November 24, 2010 at 1:12 am By:
FDA Approves Movement Disorder Drug from CNS Therapeutics: Gablofen (Baclofen Injection) for the Treatment... http://bit.ly/fTISqZ #drug
FDA Approves Movement Disorder Drug From CNS Therapeutics: Gablofen(R) (Baclofen Injection) For The Treatment Of Severe Spasticity
medicalnewstoday.com — “CNS Therapeutics announced the FDA approval of Gablofen® (baclofen injection) for use in the management of severe spasticity, giving healthcare providers a new, easy-to-administer and cost-eff” View full resource at medicalnewstoday.com
Most Recently Shared on November 26, 2010 at 2:05 pm By:
MNT Drug Approvals Health News
FDA Approves Movement Disorder Drug From CNS Therapeutics: Gablofen(R) (Baclofen Injection) For The Treatment Of Sever... http://mnt.to/3N9H
FDA Approves Movement Disorder Drug from CNS Therapeutics: Gablofen (Baclofen Injection) for the Treatment of Severe Spasticity
drugs.com — “Gablofen (baclofen) is used to treat severe spasticity. Includes Gablofen side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on November 24, 2010 at 12:22 am By:
FDA Approves Gablofen (Baclofen Injection) for the Treatment of Severe Spasticity - http://bit.ly/hZn6ge
Advertisement
